In vitro antiviral activity of lutein against hepatitis B virus

Phytotherapy Research

Volumn 24, Issue 11, 2010, Pages 1627-1630

  Pang, Ran ^a   Tao, Jun Yan ^b   Zhang, Shu Ling ^a   Zhao, Lei ^a   Yue, Xin ^b   Wang, Yue Feng ^a   Ye, Pian ^a   Dong, Ji Hua ^a   Zhu, Ying ^b   Wu, Jian Guo ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

HBeAg; HBsAg; HBV DNA; HBV promoter; Hepatitis B virus; Lutein

Indexed keywords

HEPATITIS B ANTIGEN; VIRUS DNA; XANTHOPHYLL;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOTOXICITY; DOSE RESPONSE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PROTEIN SECRETION;

ANTIVIRAL AGENTS; DNA, VIRAL; HEP G2 CELLS; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LUTEIN; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

HEPATITIS B VIRUS;

EID: 78049416799     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3155     Document Type: Article

References (17)

1. Arbuthnot P, Carmona S, Ely A. 2005. Exploiting the RNA interference pathway to counter hepatitis B virus replication. Liver Int 25: 9-15.
2. Chen CJ, Yang HI, Su J et al. 2006. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295: 65-73.
3. Chen G, Lin W, Shen F et al. 2006. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol 101: 1797-1803.
4. Choi BH, Park GT, Rho HM. 1999. Interaction of hepatitis B viral X protein and CCAAT/enhancer-binding protein alpha synergistically activates the hepatitis B viral enhancer II/pregenomic promoter. J Biol Chem 274: 2858-2865.
5. Harikumar KB, Nimita CV, Preethi KC et al. 2008. Toxicity profile of lutein and lutein ester isolated from marigold flowers (Tagetes erecta). Int J Toxicol 27: 1-9.
6. Iloeje UH, Yang HI, Su J et al. 2006. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 130: 678-686.
7. Kozuki Y, Miura Y, Yagasaki K. 2000. Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 151: 111-115.
8. Liaw YF. 2002. Therapy of chronic hepatitis B: current challenges and opportunities. J Viral Hepat 9: 393-399.
9. McMahon BJ. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49: S45-S55.
10. Moolla N, Kew M, Arbuthnot P. 2002. Regulatory elements of hepatitis B virus transcription. J Viral Hepat 9: 323-331.
11. Narisawa T, Fukaura Y, Hasebe M et al. 1996. Inhibitory effects of natural carotenoids, alpha-carotene, beta-carotene, lycopene and lutein, on colonic aberrant crypt foci formation in rats. Cancer Lett 107: 137-142.
12. Park NH, Song IH, Chung YH. 2006. Chronic hepatitis B in hepatocarcinogenesis. Postgrad Med J 82: 507-515.
13. Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84: 1005-1009.
14. Shamay M, Barak O, Doitsh G et al. 2002. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem 277: 9982-9988.
15. Stringham JM, Hammond BR, Jr. 2005. Dietary lutein and zeaxanthin: possible effects on visual function. Nutr Rev 63: 59-64.
16. Ukiya M, Akihisa T, Yasukawa K et al. 2006. Anti-inflammatory, anti-tumor-promoting, and cytotoxic activities of constituents of marigold (Calendula officinalis) flowers. J Nat Prod 69: 1692-1696.
17. Yang HI, Lu SN, Liaw YF et al. 2002. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 347: 168-174.